Navigation Links
Nutra Pharma Receives Patent for Their Multiple Sclerosis Drug
Date:10/19/2011

that primarily causes central nervous system problems. In MS, the insulating fatty material surrounding the nerve fibers, also known as myelin, which functions to speed signaling from one end of the nerve cell to the other, is attacked by cells of the immune system causing problems in signal transduction. According to the Accelerated Cure Project for Multiple Sclerosis, a national nonprofit organization, 400,000 people in the US are affected by MS and another 2 million globally. Nutra Pharma's MS drug, RPI-78M, has shown efficacy in animal models (EAE) for MS and the Company is planning new animal studies to gain more insight into the levels of protection that the drugs afford. In one study conducted in August 2007, all members of an untreated animal control group developed signs of disease with different levels of paralysis/muscle weakness. A similar group in the August 2007 study treated with RPI-78M showed no disease in 90% of the animals in both acute and chronic applications of the test. Moreover, there were no toxicities reported though the animals received doses the equivalent of 280 times a human dose.

About Nutra Pharma Corp.

Nutra Pharma Corporation operates as a biotechnology company specializing in the acquisition, licensing, and commercialization of pharmaceutical products and technologies for the management of neurological disorders, cancer, autoimmune, and infectious diseases, including Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV), Adrenomyeloneuropathy (AMN) and Pain. Additionally, the Company markets several drug products for sale for the treatment of pain under the brands Cobroxin® and Nyloxin™. For additional information about Nutra Pharma, visit: http://www.NutraPharma.com

SEC Disclaimer

This press release contains forward-looking statements. The words or phrases "would be," "will allow," "intends to," "will likely result," "a
'/>"/>

SOURCE Nutra Pharma Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Native Remedies NutraRx Brand of Natural Products for Medical Practitioners Among First to Earn Prestigious Emerson EQP Seal
2. Maxam Nutraceutics Introduces PCA-Rx as a Natural Chelation Alternative for Autism Spectrum Disorder Treatment
3. Nutraceutical Leader Announces Internal Promotions of Key Personnel
4. Synutra to Participate in Citis Greater China Investor Conference
5. Reportlinker Adds Nutraceutical Market
6. Reportlinker Adds Global Nutraceuticals Industry
7. Nutrastar to Present at the Cowen and Company 9th Annual Consumer Conference in NYC
8. Synutra to Announce Third Quarter Fiscal 2011 Financial Results
9. Colorcon Expands Nutraficient Product Portfolio to Include High Productivity, PVA-Based Formulations for Food Supplement Coating
10. ScienceBased Health and Hoya Surgical Optics, Inc. Combine Forces to Expand Reach of Evidence-Based Nutraceuticals in Ophthalmic Market and Enhance Patient Care
11. Nutrastar Announces Record 2010 Performance and Revenue Guidance for 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA ) ... 31, 2015.  The net loss and the loss from ... $13.0 million, respectively, compared to $10.7 million and $8.8 ... March 31, 2015, Alexza had consolidated cash, cash equivalents, ... "We continue to focus on ways in which ...
(Date:5/6/2015)... May 6, 2015 /CNW/ - Celebrities, bloggers and influencers across ... to spread the important message that melanoma prevention begins with ... Maria Sharapova , Hilary Duff , and parenting author ... out to their networks on Monday to share this poignant ... The David Cornfield Melanoma Fund (DCMF)-producers ...
(Date:5/6/2015)... Research and Markets ( http://www.researchandmarkets.com/research/2qs6vr/cannulas_market ... "Cannulas Market by Product (Nasal, Arterial, Arthroscopy, Ophthalmic, ... (Plastic, Metal) & End Users (Hospitals, Ambulatory Surgical ... to their offering. The global cannulas ... of 5.6% from 2015 to 2020 to reach ...
Breaking Medicine Technology:Alexza Reports 2015 First Quarter Financial Results 2Alexza Reports 2015 First Quarter Financial Results 3Alexza Reports 2015 First Quarter Financial Results 4Alexza Reports 2015 First Quarter Financial Results 5Alexza Reports 2015 First Quarter Financial Results 6Alexza Reports 2015 First Quarter Financial Results 7Alexza Reports 2015 First Quarter Financial Results 8Alexza Reports 2015 First Quarter Financial Results 9Alexza Reports 2015 First Quarter Financial Results 10Celebrities Tweet Their Support of Melanoma Awareness Month and #newfamilyrule 2Global Cannulas Market 2015 - Forecasts to 2020 with Medtronic, Edward Lifesciences, Terumo, Sorin & Maquet Holding B.V. & Co. Dominating 2Global Cannulas Market 2015 - Forecasts to 2020 with Medtronic, Edward Lifesciences, Terumo, Sorin & Maquet Holding B.V. & Co. Dominating 3
... Concert Medical, LLC today announced the launch of ... These guidewires are designed to address an extensive range of coronary ... clearance for the use and sale in the U.S. of the ... is located in Norwell, Mass. and manufactures all ...
... Mylan Inc. (Nasdaq: MYL ) today ... final approval from the U.S. Food and Drug Administration ... Nabumetone Tablets USP, 500 mg and 750 mg. The ... equivalent to Nabumetone Tablets, a treatment for osteoarthritis and ...
Cached Medicine Technology:Concert Medical Launches 'Conductor™' Family of Interventional Coronary Guidewires 2Concert Medical Launches 'Conductor™' Family of Interventional Coronary Guidewires 3Mylan Receives Approval for Nabumetone Tablets 2
(Date:5/6/2015)... RPS Revolution - a game for the ... true Rock Paper Scissors game - is now taking ... storytelling and easy to learn rules from Rock Paper Scissors, ... favorite. RPS Revolution takes the best parts of ... are grouped in set of three called Trios. Trios like ...
(Date:5/6/2015)... (PRWEB) May 06, 2015 MJNational LLC ... Mobile, (OTC: LGBI), Canna Bizcard ™ platform. This exciting ... in Investor Relations, Product Sales / Services. Now ... bring national awareness to products, services and ticker symbol ... marketing system. , MJNational LLC will provide managed support ...
(Date:5/6/2015)... 2015 Imprivata ® (NYSE: IMPR), ... David Ting will lead a discussion about the Internet ... and user authentication challenges, during Citrix Synergy ... focus on the benefits of creating a network of ... and patients can share information. It will also emphasize ...
(Date:5/6/2015)... May 06, 2015 On April 27, ... Plastic Surgery ,” compiled quotes about cosmetic surgery ... Aniston, pop singer Iggy Azalea, and Gwyneth Paltrow. For ... about having plastic surgery themselves; only a ... and its expectations of youth and beauty. (see: goo.gl/wSomih) ...
(Date:5/6/2015)... May 06, 2015 Qushanna Doby (20) was ... nearby drug treatment center in Florida while under the influence ... 4th. New surveillance tapes released by CBS4’s Peter D’Oench records ... baby. Doby’s child is around one year old. The drug ... shivering outside was not named. The residents polled by CBS ...
Breaking Medicine News(10 mins):Health News:RPS Revolution Launches Kickstarter Campaign 2Health News:RPS Revolution Launches Kickstarter Campaign 3Health News:Cannabiz Mobile Inc. Launches the Canna Bizcard ™ Platform to Support to Cannabis Market 2Health News:Cannabiz Mobile Inc. Launches the Canna Bizcard ™ Platform to Support to Cannabis Market 3Health News:Imprivata to Lead Discussion about Patient and Provider Authentication Challenges and the Internet of Things in Healthcare during Citrix Synergy 2Health News:Plastic Surgery: Sixteen Celebrities Offer their Opinion about Going Under the Knife 2Health News:Flakka Induced Mother Abandons Baby, found by Florida Drug Treatment Center; New Video Released 2
... , , MISSION VIEJO, Calif., Sept. ... the parent company of the Ensign(TM) group of skilled nursing, rehabilitative ... of Directors has declared a quarterly cash dividend of $0.045 per ... 2009 to shareholders of record as of September 30, 2009. Ensign ...
... BOTHELL, Wash., Sept. 18 SCOLR Pharma, Inc. ... September 15, 2009, the NYSE Amex LLC (the "Exchange") accepted ... disclosed listing deficiency as set forth in Section 1003(a)(iii) of ... Company,s failure to maintain stockholder,s equity of at least $6,000,000 ...
... , , LAWRENCE, Mass., Sept. ... leading manufacturer of innovative dialysis products, today announced that home dialysis ... Road Trip" with the NxStage(R) System One(TM). As a portable ... opportunity to fit hemodialysis therapy into his own lifestyle and schedule. ...
... , , , , ... hip abnormalities, combined with advances in diagnostic imaging techniques and minimally ... chronic, misdiagnosed hip pain. , , Increasingly, ... of degenerative hip disease, get patients back to their chosen activities ...
... , Statement of Andy Stern, President of ... Andy Stern, President of the Service Employees International Union, ... extremists to silence working families by attacking progressive individuals and community ... of profound change for this country -- from kitchen tables to ...
... , , HAYWARD, Calif., Sept. ... global leader in the medical aesthetics market, today announced that it ... on Tuesday, September 29, 2009 at the Grand Hyatt New York ... for 10:30 a.m. Eastern Time on September 29, 2009. Stephen ...
Cached Medicine News:Health News:SCOLR Pharma, Inc. Receives Notice from NYSE Amex LLC Regarding Compliance Plan and Listing Standards 2Health News:SCOLR Pharma, Inc. Receives Notice from NYSE Amex LLC Regarding Compliance Plan and Listing Standards 3Health News:SCOLR Pharma, Inc. Receives Notice from NYSE Amex LLC Regarding Compliance Plan and Listing Standards 4Health News:NxStage Patient Takes Dialysis Machine on Third Annual Patient Good-Will Tour 2Health News:NxStage Patient Takes Dialysis Machine on Third Annual Patient Good-Will Tour 3Health News:Early Diagnosis and Treatment of Hip Conditions is Focus of New Center 2Health News:Early Diagnosis and Treatment of Hip Conditions is Focus of New Center 3Health News:Early Diagnosis and Treatment of Hip Conditions is Focus of New Center 4Health News:Early Diagnosis and Treatment of Hip Conditions is Focus of New Center 5Health News:Working Women and Men Will Not Be Silenced by Right Wing Attack Dogs; SEIU Members and Other Working Americans Will Continue to Speak Out For the America We Believe In 2Health News:Solta Medical to Present at the Maxim Group Growth Conference 2
... optimize the accuracy and precision of Finnpipettes. ... widely recognized by customers throughout the world. ... the years and now covers a full ... filter tips, certified pure tips, stepper tips ...
MBP's 200 L large orifice tip is perfect for handling fragile cells, viscous samples and genomic....
Designed to fit the Brinkmann Tranferpette and Treff Multi-Channel 300 L Pipettors, this tip provides extra space for repeat pipetting....
... an immunometric ('sandwich') EIA for the ... serum or plasma. LH in the ... anti-LH antibodies directed at different epitopes. ... particles and the other is labelled ...
Medicine Products: